The World Health Organization (WHO) has designated CRESIB, the research centre of the Barcelona Institute for Global Health (ISGlobal), as a "WHO Collaborating Centre for Malaria Control, Elimination and Eradication". Following years of previous fruitful collaboration, the designation will systematize CRESIB activities related to WHO mandates in two key areas:
- supporting the science of malaria elimination and eradication in order to inform relevant WHO policies and guidelines,
- supporting the writing up of WHO guidelines, handbooks and reports.
Activities comprised under the umbrella of the collaborating centre designation agreement will include knowledge management functions in the context of the Malaria Eradication Scientific Alliance (MESA), coordinating the update of the Malaria Eradication Research Agenda (malERA) consultative process, and generating evidence on the feasibility of malaria elimination in determined geographical areas.
Besides, CRESIB will inform the policy setting process within the fields of control of malaria in pregnancy and, within it, the review of evidence on Intermittent Preventive Treatment in pregnancy (IPTp). It will also support the production of WHO guidelines for the treatment of severe malaria and of a comprehensive strategy on non-African malaria, specifically that caused by Plasmodium vivax, among other activities.
The designation will be effective for a period of four years as from 13 March 2013, and may be extended following a timely redesignation process.